Literature DB >> 28456355

Potential Mechanisms of Vascular Thrombosis after Microwave Ablation in an in Vivo Liver.

Jason Chiang1, Kwang Nickel2, Randall J Kimple2, Christopher L Brace3.   

Abstract

PURPOSE: To evaluate potential biologic and thermal mechanisms of the observed differences in thrombosis rates between hepatic vessels during microwave (MW) ablation procedures.
MATERIALS AND METHODS: MW ablation antennae were placed in single liver lobes of 2 in vivo porcine liver models (n = 3 in each animal; N = 6 total) in the proximity of a large (> 5 mm) portal vein (PV) and hepatic veins (HVs). Each ablation was performed with 100 W for 5 minutes. Conventional ultrasound imaging and intravascular temperature probes were used to evaluate vessel patency and temperature changes during the ablation procedure. Vascular endothelium was harvested 1 hour after ablation and used to characterize genes and proteins associated with thrombosis in PVs and HVs.
RESULTS: Targeted PVs within the MW ablation zone exhibited thrombosis at a significantly higher rate than HVs (54.5% vs 0.0%; P = .0046). There was a negligible change in intravascular temperature in PVs and HVs during the ablation procedure (0.2°C ± 0.4 vs 0.6°C ± 0.9; P = .46). PVs exhibited significantly higher gene expression than HVs in terms of fold differences in thrombomodulin (2.9 ± 2.0; P = .0001), von Willebrand factor (vWF; 7.6 ± 1.5; P = .0001), endothelial protein C receptor (3.50 ± 0.49; P = .0011), and plasminogen activator inhibitor (1.46 ± 0.05; P = .0014). Western blot analysis showed significantly higher expression of vWF (2.32 ± 0.92; P = .031) in PVs compared with HVs.
CONCLUSIONS: Large PVs exhibit thrombosis more frequently than HVs during MW ablation procedures. Biologic differences in thrombogenicity, rather than heat transfer, between PVs and HVs may contribute to their different rates of thrombosis.
Copyright © 2017 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28456355      PMCID: PMC5483190          DOI: 10.1016/j.jvir.2017.03.034

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  24 in total

1.  Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink" effect.

Authors:  David S K Lu; Steven S Raman; Darko J Vodopich; Michael Wang; James Sayre; Charles Lassman
Journal:  AJR Am J Roentgenol       Date:  2002-01       Impact factor: 3.959

2.  Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors.

Authors:  M H Denninger; Y Chaït; N Casadevall; S Hillaire; M C Guillin; A Bezeaud; S Erlinger; J Briere; D Valla
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

Review 3.  Microwave tumor ablation: mechanism of action, clinical results, and devices.

Authors:  Meghan G Lubner; Christopher L Brace; J Louis Hinshaw; Fred T Lee
Journal:  J Vasc Interv Radiol       Date:  2010-08       Impact factor: 3.464

4.  Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update.

Authors:  Muneeb Ahmed; Luigi Solbiati; Christopher L Brace; David J Breen; Matthew R Callstrom; J William Charboneau; Min-Hua Chen; Byung Ihn Choi; Thierry de Baère; Gerald D Dodd; Damian E Dupuy; Debra A Gervais; David Gianfelice; Alice R Gillams; Fred T Lee; Edward Leen; Riccardo Lencioni; Peter J Littrup; Tito Livraghi; David S Lu; John P McGahan; Maria Franca Meloni; Boris Nikolic; Philippe L Pereira; Ping Liang; Hyunchul Rhim; Steven C Rose; Riad Salem; Constantinos T Sofocleous; Stephen B Solomon; Michael C Soulen; Masatoshi Tanaka; Thomas J Vogl; Bradford J Wood; S Nahum Goldberg
Journal:  J Vasc Interv Radiol       Date:  2014-10-23       Impact factor: 3.464

5.  Heat shock protein 70 expression following hepatic radiofrequency ablation is affected by adjacent vasculature.

Authors:  Neil Bhardwaj; John Dormer; Fateh Ahmad; Andrew D Strickland; Gianpiero Gravante; Ian Beckingham; Kevin West; Ashley R Dennison; David M Lloyd
Journal:  J Surg Res       Date:  2010-10-23       Impact factor: 2.192

6.  Image-guided thermal ablation of tumors increases the plasma level of interleukin-6 and interleukin-10.

Authors:  Joseph P Erinjeri; Contessa T Thomas; Alaiksandra Samoilia; Martin Fleisher; Mithat Gonen; Constantinos T Sofocleous; Raymond H Thornton; Robert H Siegelbaum; Anne M Covey; Lynn A Brody; William Alago; Majid Maybody; Karen T Brown; George I Getrajdman; Stephen B Solomon
Journal:  J Vasc Interv Radiol       Date:  2013-04-10       Impact factor: 3.464

7.  Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors.

Authors:  David S K Lu; Steven S Raman; Piyaporn Limanond; Donya Aziz; James Economou; Ronald Busuttil; James Sayre
Journal:  J Vasc Interv Radiol       Date:  2003-10       Impact factor: 3.464

8.  Flow-dependent vascular heat transfer during microwave thermal ablation.

Authors:  Jason Chiang; Kieran Hynes; Christopher L Brace
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2012

9.  Risk of tumour progression in early-stage hepatocellular carcinoma after radiofrequency ablation.

Authors:  M L Fernandes; C-C Lin; C-J Lin; W-T Chen; S-M Lin
Journal:  Br J Surg       Date:  2009-07       Impact factor: 6.939

10.  Comparison of portal vein doppler indices and hepatic vein doppler waveform in patients with nonalcoholic fatty liver disease with healthy control.

Authors:  Ehsan Solhjoo; Fariborz Mansour-Ghanaei; Roghaeyh Moulaei-Langorudi; Farahnaz Joukar
Journal:  Hepat Mon       Date:  2011-09       Impact factor: 0.660

View more
  1 in total

1.  A comparison study of microwave ablation vs. histotripsy for focal liver treatments in a swine model.

Authors:  Emily A Knott; Annie M Zlevor; J Louis Hinshaw; Paul F Laeseke; Colin Longhurst; Jenifer Frank; Charles W Bradley; Allison B Couillard; Annika E Rossebo; Zhen Xu; Fred T Lee; Timothy J Ziemlewicz
Journal:  Eur Radiol       Date:  2022-09-01       Impact factor: 7.034

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.